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To those who would relegate the permanent artificial heart to medical 
history, we offer Robertlarvik. He did it once, and he'll do it again . 
n Y 
[]] 
NAN UNASSUMING OFFICE 
on the 39th floor of a high-
rise in New York City, over-
looking midtown Manhat-
tan and the Hudson River, 
Dr. Robert Jarvik sits at his 
Silicon Graphic IRIS super work station 
refining the design of his latest artificial heart. 
In front of him, on the computer screen, the 
new heart rotates in three dimensions. On the 
walls behind him hang framed newspaper 
and magazine clippings documenting the ex-
ploits of the Jarvik-7. On a counter to the side 
sit several old Jarvik hearts, including part of 
the pyrolitic carbon and titanium device that 
kept Barney Clark alive for 112 days. 
It's been slightly more than six years since 
Clark- the recipient of the first permanent 
artificial heart- died on March 23, 1983. Six 
years since the nation and the world held its 
breath for the promise of new life. 
It's been almost three years since the 
death of Bill Schroeder, the second perma-
nent heart recipient, who lived for a record 
620 days with the Jarvik-7. T he three other 
recipients of the permanent Jarvik-7, Murray 
Haydon, Jack Burcham, and Leif Stenberg, 
died in the interim. 
In the early days, when Clark was still a 
hero and families sat down to watch the news 
each night to check his progress, the artificial 
heart was referred to as a 'medical milestone'. 
But after recurring renal failure, after compli-
cations in Clark's lungs, kidneys, and intes-
tines, after Schroeder suffered numerous 
debilitating strokes, after Burcham died only 
10 days after his implant, the euphoria began 
to wane. 
In its place rose cries of ethical concern. 
Disturbing questions were raised-regarding 
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quality of life, the medical team's ability to 
profit financially from the heart, the patient 
selection process, and the hospital's consent 
form. 
The emphasis of the Jarvik-7 shifted from 
its use as a permanent device to that of a 
bridge to transplantation- that is, to prolong 
the lives of people whose death is imminent 
until a suitable human heart can be found. 
Approximately 140 such surgeries have 
occurred; more than half of those patients 
have been totally rehabilitated. Although it's 
still considered experimental surgery, many 
say the device has performed flawlessly when 
used as a bridge. 
Fewer and fewer people view the perma-
nent artificial heart as a viable solution for the 
near or distant future. In May 1988, the Na-
tional Heart, Lung and Blood Institute, 
which has monitored federally funded artifi-
cial heart research since 1964, terminated 
government support of total artificial heart re-
search. T he Institute's director, Claude Len-
fant, argued that the human body couldn't 
seem to tolerate the artificial heart. Instead, 
research would concentrate on partial ventri-
cle assist devices that were nearly ready for 
clinical testing in humans. 
A New York Times editorial applauded the 
decision, calling the permanent artificial 
heart "the Dracula of medical technology." 
Wrote the paper: "At long last, the institute 
has found the resolve to drive a stake through 
its voracious creation." Despite that criticism, 
some government funding for permanent 
artificial heart research remains, thanks to the 
efforts of a band of influential senators who 
successfully lobbied for reinstatement of an 
artificial heart program. 
But while some funding has been re-
newed, ethical dissonance regarding a per-
manent artificial heart remains in both 
medical circles and the public. Some believe 
that human heart transplantation is the only 
practical solution to advanced heart disease. 
Not Robert Jarvik. His belief in the pro-
mise of a permanent artificial heart is stronger 
than ever. 
Jarvik holds none of the four government 
contracts funding permanent artificial heart 
research. He supports his research indepen-
dently, with his own money and with funding 
from the private sector. Away from a major 
medical center, away from federal constraints 
on his creativity, energized by the pulse of the 
city below him, Jarvik perfects his heart. He 
believes a successful permanent artificial 
heart could save 500,000 lives over 10 years. 
And he believes his revolutionary new device 
is the one that will do it. [I] HE SIZE OF AN EGG. THAT'S HOW Jarvik describes his revolutionary 
new Jarvik 2000 heart. A futuristic 
name for a futuristic product. 
The Jarvik 2000, which is trademarked, 
uses what's known as the intraventricular ap-
proach, "a completely new concept," says 
Jarvik. Instead of replacing the human heart, 
instead of actually cutting it out and replacing 
it with something else, the Jarvik 2000 is 
placed inside the left ventricle of the natural 
heart. In a case where both sides of the heart 
would need to be supported, two devices 
would be implanted. Nearly 70 percent of 
patients will need only one. Jarvik believes 
the "heart within a heart" will eliminate the 
threat of infection that plagued the Jarvik-7. 
The beauty of the new heart is its simpli-
city. It uses a hydrodynamic axial flow 
pump--similar to turbine blading on a jet en-
gine or a ship propeller-allowing the whole 
system to function with a single moving part. 
It requires no heart valves and is expected to 
be practically silent when implanted. 
The Jarvik 2000 will be powered by an 
implanted electric motor, within the chamber 
of the heart, that drives the rotor magneti-
cally. The patient will wear a battery vest con-
nected to the heart at a socket in the patient's 
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chest. A battery weighing just a few pounds 
would last six to eight hours. A cable and a 
wall plug could be used while sleeping. The 
patient would have full mobility and a high 
quality of life. "In terms of simplicity, mini-
aturization, and long-term reliability, it has a 
great deal of potential," says] arvik. 
Right now the heart lives only in Jarvik's 
computer, but he hopes to have working 
models by the end of the summer. The 
project will then require three to four years of 
animal studies before human implants could 
begin, with several more years of testing on 
humans before the device could be more 
widely available. Several pneumatic centers 
have expressed interest in housing the 
project once it proceeds. For now, it rests with 
Jarvik. 
"It's not sufficient to just be an inventor or 
a designer or a physician these days," he says. 
"You have to think about integrating the 
whole thing and you have to take into ac-
count the issues such as the environment in 
terms of the public attitude toward new tech-
nology and health." To meet this challenge, 
Jarvik draws on his experience as a pioneer in 
artificial heart research-most importantly, 
the lessons learned from the ] arvik -7. [I] ARVIK BEGAN WORKING ON THE artificial heart as a $100-a-week 
lab assistant to Dr. William Kolff, 
head of the artificial organs 
department at the University of Utah and the 
inventor of the first successful kidney dialysis 
machine. 
Although he's commonly referred to as 
the "inventor" of the artificial heart, Jarvik ac-
tually adapted existing technology, revolu-
tionizing ir in the process. "I took what was a 
general concept into the realm of being able 
to be used clinically," he says. 
The premise of the artificial heart has cir-
culated through medical circles for more than 
150 years, bur did nor materialize until the 
early fifties when a mechanical heart devel-
oped by F. D. Dodrill of General Motors was 
used to bypass the heart of a patient for 50 
minutes during surgery. 
Kolff started experimenting with a total 
artificial heart in 1957. Early models were im-
planted in Jogs and calves with limited suc-
cess. In 1969, Dr. Denton Cooley of the 
1exas Heart Institute implanted an artificial 
heart in a man to keep him alive until a 
suitable heart could be found for transplant. 
He lived for 60 hours with rhe heart before 
his transplant, but died of complications only 
32 hours later. 
Three years later an artificial heart de-
signed by Clifford K wann-Gett, a member of 
Kolffs artificial organs ream, eliminated ear-
~~ 
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lier problems involving mechanical dysfunc-
tion. Survival times for experimental animals 
increased, but the devices continued to mal-
function after about two weeks of use. 
Then came Jarvik. His first heart, the Jar-
vik-3, replaced rhe mbber constmcrion of old 
hearts with multiple layers of a smooth elastic 
material similar to the lycra used in girdles. 
The heart was better adapted to fit the 
anatomy of lab animals, who lived up to four 
months with the device. 
In 1976, researchers implanted a Jarvik-5 
into a calf named Abe be, who lived for an un-
precedented six months. Later a calf named 
Alfred Lord Tennyson was kept alive for nine 
months with the heart. 
With a view toward imminent human 
usage, Jarvik developed a new heart that was 
smaller than the others, one that would fir in-
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side an average human chest. Like irs 
predecessors, it would replace the two lower 
ventricles of the human heart (the pans that 
pump blood to the rest of the body) and 
would be attached to the natural atria (the 
upper chambers) of the human heart. It 
would be powered pneumatically- by com-
pressed air-from an electrical unit con-
nected to the patient's body by tubes. It was 
called the Jarvik-7. 
Concerned that funding for the artificial 
organs program made available by the Na-
tional Institutes of Health (NIH) might 
someday be cut off, Kolff formed a satellite 
laboratory of rhe university- a spin-off busi-
ness venture called Kolff Associates, and later 
Kolff Medical-with Jarvik as his principal 
associate. As Kolff was petitioning the Food 
and Drug Administration (FDA) for permis-
3
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sion to implant the Jarvik-7 in a human, 
Jarvik took the helm of the company as presi-
dent and chief executive officer. 
Although the FDA granted Kolff's re-
quest in September 1981, it was more than a 
year before a subject was found that met the 
stringent FDA and University of Utah 
requirements. 
On December 2, 1982, a retired dentist 
suffering from cardiomyopathy-degenera-
tive and irreversible heart disease-made 
history by receiving the first permanent artifi-
cial heart. Dr. William DeVries of the Univer-
sity of Utah performed the seven-and-a-half-
hour surgery; Jarvik assisted. With Ravel's 
Bolero playing in the background, Barney 
Clark was given a second chance at life. 
Within four years, four more permanent 
implants would occur and all five men would 
die. Numerous side effects and complica-
tions arose: kidney failure, pneumonia, diar-
rhea, blood clots that caused strokes, and 
limited mobility due to the bulky pneumatic 
system. With each patient, however, the 
.. ~knew 
that my father 
was going to die of 
heart disease, and 
I was trying to make 
a heart for him, " 
J arvik has said. 
"/was too late. " 
• • • 
cause of death was infection at the site of the 
prosthetic device-stemming from the drive 
lines that connected the heart to the power 
source. The pericardia! membrane surround-
How the 2000 Works 
The Jarvik 2000 artificial heart will not replace the 
human heart, but will fit inside the cavity of 
the left ventricle. The egg-sized device will 
assume the function of the ventricle, 
pumping oxygenated blood through 
the aorta back into the body. It is 
operated by a single moving part, 
powered magnetically by an electric 
motor in the heart's chamber, 
which is connected through 
the chest to a portable 
battery vest. 
LEFT VENTRICLE 
ing the artificial heart had an inadequate 
blood supply to fight against infection. 
Jarvik says that while the Jarvik-7 
demonstrated the possibility of long-term 
survival with the artificial heart, his belief that 
the compressed-air prosthesis was advanced 
enough to be used on a widespread per-
manent basis was "probably the biggest mis-
take I have ever made .... I think it's 
appropriate to recognize the Jarvik-7 heart as 
a device of limited clinical applicability now, 
but a good research device," he says. 
Undeterred from his mission, Jarvik set his 
sights on redeveloping the artificial heart and on 
running KolffMedical. Taking the firm public, 
he raised millions from investors. Kolff resigned 
as chairman in 1984 and the company changed 
it's name to Symbion Inc. (a combination of 
symbiosis and bionic). In 1986 Symbion was 
listed in Inc. magazine among the fastest-grow-
ing small companies in America. 
And then another blow. In 1987, the E.M. 
Warburg Pincus Co., a New York-based ven-
ture capital firm and a major investor in Kolff 
Medical, instigated a successful stock take-
over of Symbion. Jarvik was ousted. Every-
thing he'd worked for was crumbling at once. [§] EVEN YEARS BEFORE BARNEY Clark received his Jarvik-7, Rob 
Jarvik's father, a physician, died 
after open heart surgery. 
"I knew that my father was going to die of 
heart disease, and I was trying to make a heart 
for him," Jarvik has said. "I was too late." 
Growing up in Stamford, Connecticut, 
Jarvik was "a kid who was always mentally 
disassembling things and putting them back 
together," he says. He enjoyed dabbling in 
the sciences, and according to the reminis-
cences of a boyhood friend, used to perform 
autopsies on dead animals found on the side 
of the road. 
During high school Jarvik worked as an 
orderly at Stamford Hospital, where his father 
performed general surgery. He often ob-
served surgery at his father's side, and one 
day, after watching a nurse struggle with a su-
ture, invented a gun-like device that auto-
matically staples-off blood vessels. The 
Jarvik Suture Machine, as he called it, was the 
first of his five patents (he has five more 
pending on artificial heart and artificial hear-
ing devices). 
He enrolled in Syracuse University as an 
architecture major, but switched to pre-med 
after his father suffered an aortic aneurysm. 
Jarvik says he was not "a conventional 
thinker," and did not put his major effort into 
his studies, a view corroborated by SU 
chemistry professor Roger C. Hahn. "He al-
ways went on flights of fantasy," says Hahn. 
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The result was a 2.8 grade point average 
that managed to keep him out of more than 
15 medical schools. Mter graduating with a 
degree in zoology in 1968, Jarvik married his 
college sweetheart, Elaine Levin, a 1967 SU 
grad, and packed off for Italy, where he en-
rolled at the University of Bologna medical 
school. Classes were canceled frequently due 
to student strikes and he spent much of his 
time pondering theories of the universe. 
After two years the couple returned to New 
York where Jarvik earned a master's degree in 
occupational biomechanics from New York 
University. 
Still determined to earn an M.D., Jarvik 
moved to Salt Lake City to work for Kolff, 
and with his mentor's recommendation was 
admitted to the University of Utah College of 
Medicine the following year. He had taken a 
model of his hean with him to his entrance 
interview. "I come to you with my hean in my 
hands," he told the administrators. 
Mter graduating in 1976, Jarvik eschewed 
an internship and a residency in favor of 
working full-time on the artificial heart with 
Kolff. He served as assistant director of the 
experimental laboratories of the university's 
division of artificial organs, and as an assistant 
research professor in surgery and bioengin-
eering. 
These were roller coaster years for Jarvik. 
With the implant of the Jarvik-7, he was 
transformed from an anonymous researcher 
to a household name. During the early 80s he 
was named inventor of the year by the Na-
tional Inventors Hall of Fame, received an 
honorary doctor of science degree from Syra-
cuse University, was chosen by Esquire maga-
zine as one of the outstanding Americans 
under 40, received a Gentleman's Quarterly 
Manstyle Award, and appeared as one of the 
men beneath the eye patch in the Hathaway 
shirt ads. 
Despite the fame and glory, he was under 
tremendous strain, pulled between commit-
ments to Symbion, his patients, his family, 
and promotion of the artificial heart. "I was 
emotionally involved in the lives of the 
patients, and I was also traveling all over to 
promote the program,'' Jarvikhas said. "Even 
though I had a general purpose, I felt quite 
scattered." His marriage ended in 1985. His 
tenure as a corporate executive ended two 
years later. 
With nothing to do but start over, Jarvik 
began a new life. He moved to New York 
City, remarried (see related story), and founded 
Jarvik Research to continue his work on the 
artificial heart, a mission that pervades all 
aspects of his life. 
It's no longer a business to Jarvik, but a 
long-term scientific research project. And 
f .. l fter 
graduating in 1976, 
Jarvik eschewed an 
internship and a 
residency in favor of 
workingfu/1-time on 
the artificial heart. 
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foremost in his mind are the names Clark, 
Schroeder, Haydon, Burcham, and Stenberg. 
"These were people who I view as having 
had their lives prolonged," says Jarvik. " ... 
They [each]lived an average of nine months 
when their life expectancy was probably no 
more than a week or maybe days in some of 
the cases . .. I don't think that kind of thing 
makes a person in medicine want to stop. It 
just makes you all the more interested in 
working it through so it can be better." [I] N 1985, IN AN ATIEMIT TO REGU-late the artificial heart research 
that was already in full swing, the 
FDA established guidelines ad-
dressing the controversial issue of human ex-
perimentation. The New York Times wrote 
that the guidelines were "framed to yield the 
most knowledge at the least risk and pain to 
patients," an issue that looms over Jarvik as 
he develops the Jarvik 2000. 
"It's a question of addressing the specific 
things that we learned in the long-term use of 
the Jarvik-7," says Jarvik, "making ap-
proaches to the major problems." 
Those issues, of course, involve quality of 
life, mobility, and freedom of complications 
related to the heart. The 2000, Jarvik says, 
has been the first opponunity to take all the 
information learned from the Jarvik-7 and 
think creatively about how to solve those 
problems, which he now believes he's done. 
But there are other issues, involving the 
allocation of medical funds for research that 
may not effect a wide segment of the popula-
tion. One NIH ethicist questions the use of 
scarce resources on treatment for a disease 
that overwhelmingly affi icts "upper-middle-
class white males," rather than on something 
like prenatal care. "It's a question of getting 
the most that we can for what we pay," he 
says. 
It should be noted, however, that heart 
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disease is the nation's leading cause of death, 
causing nearly 800,000 deaths at a cost of$83 
billion annually. Every year, nearly 30,000 
lives could be saved by heart transplant, with 
only 1,500-some donor heans available. 
Often it comes down to money. Oppo-
nents of the artificial hean frequently cite the 
$240 million drained out of the NIH in the 
last 24 years for artificial heart research. But 
less than $10 million of those funds were 
used on development of the Jarvik-7, the 
majority supponing hean-assist devices, bio-
instrumentation, and biomaterials. No fed-
eral monies have assisted any of the Jarvik-7 
patients, permanent or bridge. 
Jarvik isn't worried about money. His 
research has never been funded in great part 
by government support and he doesn't see 
that changing in the near future. 
"I don't think any of the government-
funded systems have the potential to be prac-
tical," says Jarvik. "The problem with the 
NIH programs is that they have pretty much 
dictated the things that people had to do in 
order to get funding .. .. Some of the more 
creative and better ideas could not even be 
submitted under the contract programs." 
And Jarvik sees the 2000 as being a veri-
table medical bargain. "I think that the Jarvik 
2000 is going to be durable for more than 10 
years," he says. "The cost of it is going to be 
lower than heart transplant when you carry it 
over long term, particularly since it's not 
going to require $6,000 to $8,000 a year of 
drugs for follow-up .. .. I think it will be less 
than dialysis. Nursing home care can cost 
$40,000 a year. For roughly half that amount I 
think we'll be able to rehabilitate people to have 
a fully mobile lifestyle at home and back to 
work." 
Jarvik says there is a "zero chance" that 
the anificial heart will ever be a significant 
health care cost to the country. "It never is 
going to be a billion dollar item or more un-
less it's extremely successful," he says. "And 
if it's so successful that it can be applied that 
widely then it will be very valuable. There is 
not much risk in my mind that it becomes a 
thing in which a large amount of cost is ex-
pended for very little value." 
He believes the Jarvik 2000 has an excel-
lent chance of becoming equivalent to heart 
transplants in terms of cost and patient qual-
ity of life. If so, he will be several steps closer 
to a goal he set for himself nearly two decades 
ago when he began his artificial heart re-
search. As he wrote in 1981, in an article titled 
"The Artificial Heart" for Scientific American: 
"If the anificial heart is ever to achieve its ob-
jective, it must be more than a pump. It must 
also be more than functional, reliable, and 
dependable. It must be forgettable." 
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So WHo BALANCES THE CHEClfffiOOK? 
[I] hey've been dubbed "the smartest couple in the 
world," and "a true meeting 
of the minds." Whatever the 
label, the marriage of artificial heart 
pioneer Dr. Robert Jarvik and Marilyn vas 
Savant, who has the highest intelligence 
ever measured, is undoubtedly a cerebral 
love affair. 
The couple met in 1986 in what be-
came a highly reported courtship. Jarvik 
was captivated by vas Savant, apparently 
after reading a media story about her 
228 10 (88 points higher than ordinary 
genius). He got vas Savant's unlisted 
phone number from mutual acquaint-
ances and left a message with her 
secretary that he was interested in 
meeting her. 
Vas Savant was less than thrilled, 
imagining him to be a dull , research type. 
But after seeing a bare-chested photo of 
the athletic physician in Vanity Fair, her 
interest was piqued .. She returned his call. 
The couple began to speak for hours a 
day on the telephone. A month after the 
first conversation they had a "date:" a 
weekend together in Los Angeles (he was 
living in Salt Lake City, she in New York). 
Jarvik proposed five days after meeting 
vas Savant in person. They were married a 
year later in a ceremony at the Plaza Hotel. 
Jarvik made their wedding rings out of 
gold-trimmed pyrolitic carbon-a per-
manent substance he used for the valves 
of the Jarvik-7. 1saac Asimov escorted the 
bride down the aisle. Tom Gaidosh, who 
I ived with a Jarvik-7 for four days in 1985 
before receiving a heart transplant, was 
best man. 
Two years later, they are still clearly 
enamored of each other and spend nearly 
all their time together. Vas Savant, who 
retains her mother's maiden name, 
describes her husband as "a hero" and 
"absolutely the most brilliant person I've 
ever met." 
Jarvik, who believed he would never 
remarry, credits his wife with dramatically 
changing his life. "I've learned a great 
deal from her," he says. She has taught 
him to have more patience with his heart 
research. "To sum it up, I've matured a 
great deal since I've known her," he says. 
They live and work together in New 
York City ("the intellectual capital of the 
world," says Jarvik), their joint offices 
across the hall from their apartment. 
The Jarviks travel nearly 50 percent of 
the year: Paris, Rome, Caracas, and al-
most anywhere in the United States. When 
at home, they live by routine. Up at dawn 
for a quick cup of coffee before venturing 
across the hall to work. They spend the 
morning at their computers: Jarvik work-
ing with computer-aided design (which 
vas Savant is learning to use), vas Savant 
at her IBM PC, where she works on her 
column for Parade magazine or on her 
book- a futuristic political thriller. 
By afternoon, they're generally working 
together, responding to mail and tele-
phone calls and doing some collaborative 
thinking. "''ll come up with some almost 
off-the-wall suggestions for the heart," 
says vas Savant, "because I can't tell , 
frankly, what is off the wall. He can tel l. I 
tell him these things and sometimes they 
set him thinking." 
Jarvik uses his wife to keep his enthu-
siasm in check. "She is very interested in 
what constitutes actual reality rather than 
wishful thinking," he says. 
They eat dinner out nearly every night 
(vas Savant does not cook, "for humanitar-
ian reasons," she says), generally walking 
to ethnic restaurants in the neighborhood. 
On the rare occasion that they dine at 
home. it's Jarvik who prepares the meal. 
After dinner it's back to the office, 
where they work uninterrupted until one 
o'clock or so. Jarvik believes it's a fallacy 
to distinguish between work and leisure. "I 
don't have any spare time," he says. 
"I spend time with life. I think there's such 
a thorough interaction between what con-
stitutes wo rk and what constitutes per-
sonall ife, liie of the mind, etc., that it all 
comes together." And it always involves 
matters of the heart. -R.G.L. 
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